Navigation Links
Advanced Life Sciences Announces Outcome of FDA's Anti-Infective Drugs Advisory Committee Review of Restanza(TM) (cethromycin)
Date:6/2/2009

CHICAGO, June 2 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS) announced today that the FDA's Anti-Infective Drugs Advisory Committee voted in the majority that Restanza(TM) (cethromycin) demonstrated safety for the outpatient treatment of adults with mild-to-moderate community acquired pneumonia (CAP) (11 positive, 3 negative, 1 abstaining). However, the committee voted that Restanza did not demonstrate efficacy in the treatment of CAP (3 positive, 11 negative, 1 abstaining).

(Logo: http://www.newscom.com/cgi-bin/prnh/20080218/ALSLOGO)

"We believe in Restanza's potential and remain committed to its development. We were particularly encouraged by the supportive comments of several members of the committee relative to their positive review of the safety profile of Restanza, the therapeutic need for more effective treatments for CAP and their interest in seeing the company pursue further development," said Dr. Michael Flavin, Chairman and CEO of Advanced Life Sciences. "As we have throughout the review process we will continue to work closely with the FDA as they complete their assessment of the Restanza new drug application (NDA)."

Although it is not binding, the Committee's recommendation will be considered by the FDA as it completes its review of Restanza's NDA in CAP. The FDA has established a Prescription Drugs User Fee Act (PDUFA) date of July 31, 2009 for the Restanza NDA.

Conference Call Details

Advanced Life Sciences will host a conference call and live webcast at 8:30 a.m. Eastern Time on Wednesday, June 3, 2009 to discuss the outcome of the AIDAC Review.

The conference call will be webcast simultaneously over the Internet. Please visit the Investor Relations section of the Advanced Life Sciences corporate website '/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. PharmAthene Submits Proposal to BARDA in Response to Broad Agency Announcement for Advanced Research and Development for Valortim(R)
2. Medivation Announces Positive New Efficacy Data From Phase 1-2 Trial of MDV3100 in Advanced Prostate Cancer Patients
3. Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
4. Entremed Presents Results of ENMD-2076 Phase 1 Study in Advanced Cancer Patients
5. Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
6. Proteolix Presents Phase 1b/2 Clinical Data for Carfilzomib in Advanced Solid Tumor Patients at the 2009 ASCO Annual Meeting
7. Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology
8. Induction Chemotherapy Followed by ChemoRadiotherapy Increased Time-to-Treatment Failure Compared to ChemoRadiotherapy Alone in Patients With Unresectable Locally Advanced Head & Neck Cancer
9. Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401s Activity in the Treatment of Advanced Metastatic Renal Cell Cancer
10. New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer
11. Celladon Provides MYDICAR(R) Program Update of First-In-Human Trial for Advanced Heart Failure at American Society of Gene Therapy Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 2013 Amerivet Solutions, LLC ( AMERIVET ... of government from Federal to Municipal, is pleased ... to include complex metal design and fabrication manufacturing. ... complex aluminum parts for the Defense Logistics Agency ... to service government contracts," states Richard Bergen ...
(Date:6/19/2013)... 19, 2013 DST Health Solutions, LLC (DSTHS), ... health plans, integrated delivery systems, and health care providers, ... Management Service (MDMS) has jumped significantly. ... the pricing of medical prescription drug claims, MDMS ... their medical drug claims processes. As specialty drug demand ...
(Date:6/19/2013)... June 19, 2013 /PRNewswire-iReach/ -- Today leading web researchers ... data ranking Pharmaceutical web sites for usability, engagement, and ... Experience Cloud platform, which compares how people experience sites ... web. The top three performers are easier ... overall. The bottom performers have usability problems, lack aspects ...
Breaking Medicine Technology:Amerivet Solutions Expands to Manufacture Complex Metal Designs 2Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 2Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 3Sunovion tops new Change Sciences User Experience Rankings for Pharmaceutical Industry while McNeil-PPC ranks worst overall 2
... Fourth Annual Medical Product Outsourcing (MPO) Symposium kicks off ... strategist and entrepreneur Julia S. Rasor, founder of the ... device manufacturing efficiency by providing real-world examples of rudimentary ... flounder as different functional groups do their best to ...
... General Dynamics Information Technology, a business unit of ... awarded a contract to support the U.S. Army Medical ... medical facilities and transition to newly constructed facilities. The ... awarded by the U.S. Army Corps of Engineers, has ...
Cached Medicine Technology:MPO Symposium Keynote to Address Organizational Strategies for Medical Device Manufacturers 2General Dynamics Awarded Contract to Outfit and Transition U.S. Army Medical Facilities 2General Dynamics Awarded Contract to Outfit and Transition U.S. Army Medical Facilities 3
(Date:6/19/2013)... Citi Bike has come to New York City in a big ... for sure how many patients will choose to take advantage of ... In fact, he’s happy about anything that might help his ... convenient for them to visit his office at 133 East 58th ... at Back and Body Medical and an experienced NYC chiropractor ...
(Date:6/19/2013)... 2013 The Journal of Parasitology – ... computer software, it creates questions of ethics. For scientific ... an already published case shows, scientific publications need clear ... The Journal of Parasitology features a commentary ... 2004 article published in the Journal of the New ...
(Date:6/19/2013)... LOS ANGELES (June 19, 2013) In what is ... with the most common form of hereditary dystonia ... experts in deep brain stimulation report good success ... director of the Movement Disorders Program at Cedars-Sinai Medical ... chief of the Division of Neurosurgery at Beth Israel ...
(Date:6/19/2013)... understanding of the genetic process that can lead to ... lesions for some women, and also raises a warning ... cases suggesting they could actually trigger the cancer ... a clearer picture of the chromosomal and genetic changes ... to chronic infection and, in less than 1 percent ...
(Date:6/19/2013)... For those familiar ... name of the 10/90 gap: only 10 per cent of ... 90 per cent of the global disease burden. It was ... initiative (DNDi) came into being in 2003. Coinciding with its ... Foundation Frontiers of Knowledge Award in the Development Cooperation category. ...
Breaking Medicine News(10 mins):Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 2Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 3Health News:Altered Photo in Journal Article Illustrates the Need for Manipulation Guidelines 2Health News:Long-term study reports deep brain stimulation effective for most common hereditary dystonia 2Health News:Genetics of cervical cancer raise concern about antiviral therapy in some cases 2Health News:DNDi receives the BBVA Foundation Frontiers of Knowledge Award in Development Cooperation 2Health News:DNDi receives the BBVA Foundation Frontiers of Knowledge Award in Development Cooperation 3Health News:DNDi receives the BBVA Foundation Frontiers of Knowledge Award in Development Cooperation 4Health News:DNDi receives the BBVA Foundation Frontiers of Knowledge Award in Development Cooperation 5
... by progressive memory loss, decline in language skills and ... ageing population.// ,A recent paper in the ... in drug discovery. Hong-Yu Zhang, the author of the ... strategy in drug discovery is limited, which has stimulated ...
... responds to a diverse range of insults, such as ... wide range of cell types of the immune system, ... The inflammatory response, although essential for fighting infection, may ... anti-inflammatory mediators, cytokines and lipid mediators being the key ...
... Thompson and colleagues from University of Rochester Medical ... patients treated with corticosteroids that Corticosteroids is the ... mononucleosis, including severe airway compromise mononucleosis. The results ... of Otolaryngology – Head and Neck Surgery, JAMA ...
... of adults, rates of some pain conditions - particularly ... ranging from 20-50% of the teenage population.// ... are more prevalent in adult women than in men. ... associated with increased risk of migraine. Use of hormone ...
... for the development of kidney disease and is the ... However, whether pre-diabetes is associated with the development of ... declines in kidney function are present early on among ... to prevent the progression of kidney disease. Recently, researchers, ...
... have discovered that a deceptively simple sugar is in ... ,The discovery reveals that, when disturbed, this process ... to properly control the steps and timing of cell ... as O-GlcNAc (pronounced oh-GLUCK-nack), is used inside cells to ...
Cached Medicine News:Health News:The ideal composition of intravenous lipid emulsion 2Health News:Pubertal development may predispose women to pain and other symptoms 2Health News:Development of kidney disease in adults with pre-diabetes 2Health News:Sugar Helps Control Cell Division 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: